BPT.L

Bridgepoint Group plc
Bridgepoint Group - Additional Listing
25th March 2025, 16:30
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 1186C
Bridgepoint Group plc
25 March 2025
 

Bridgepoint Group plc
 ("Bridgepoint" or the "Company")

 

Additional Listing

Bridgepoint announces that it intends to issue 1,762,501 ordinary shares of £0.00005 each ("New Ordinary Shares") to satisfy vesting awards under Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.

An application has been made for the admission of the New Ordinary Shares to listing on the Official List and to trading on the LSE's main market for listed securities.

Admission is expected to occur on 28 March 2025. 

In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules, Bridgepoint announces that its total issued share capital following the issue of the New Ordinary Shares will comprise:

•

825,563,402 ordinary shares of £0.00005 each with voting rights; and

•

500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred share of £0.01, each with no voting rights.

Bridgepoint holds no shares in treasury. Following the issue of the New Ordinary Shares the total number of voting rights in the Company will therefore be 825,563,402, and this figure may be used by shareholders at such time as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Bridgepoint under the Disclosure Guidance and Transparency Rules.

 

ENQUIRIES

 

Bridgepoint

 

Analysts and investors

Adam Key

Adam.Key@bridgepointgroup.com
+44 7833 748010

 

Media

Christian Jones

Christian.Jones@bridgepointgroup.com

+44 20 7034 3500

 

FGS Global (Public Relations Adviser to Bridgepoint)

James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

Bridgepoint-LON@fgsglobal.com

 

 

Issued by Bridgepoint Group plc

LEI: 213800KFNMVI8PDZX472

Registered in England and Wales no. 11443992

Registered office: 5 Marble Arch, London, W1H 7EJ

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSQELFLEXLLBBF]]>
TwitterFacebookLinkedIn